Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma

Liver cancer is a significant contributor to the cancer burden, and its incidence rates have recently increased in almost all countries. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is the second leading cause of cancer-related deaths worldwide. Because of the l...

Full description

Saved in:
Bibliographic Details
Published in:Cells (Basel, Switzerland) Switzerland), 2023-09, Vol.12 (18), p.2260
Main Authors: Salehi, Mahsa, Lavasani, Zohre Miri, Keshavarz Alikhani, Hani, Shokouhian, Bahare, Hassan, Moustapha, Najimi, Mustapha, Vosough, Massoud
Format: Article
Language:English
Subjects:
Antibodies
Antigens
Biomarkers
Biopsy
Cancer cells
Cancer therapies
circulating tumor cells
Diagnosis
early diagnosis
Epidermal growth factor
Flow cytometry
HCC biomarker
Hepatocellular carcinoma
Hepatoma
Identification and classification
Liver cancer
Metastasis
Physiological aspects
Review
Tumor cells
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c564t-59d072beb3eddf8ea94a897581b64fa45f1c41178528384af2d33511789b4b9c3
cites cdi_FETCH-LOGICAL-c564t-59d072beb3eddf8ea94a897581b64fa45f1c41178528384af2d33511789b4b9c3
container_end_page
container_issue 18
container_start_page 2260
container_title Cells (Basel, Switzerland)
container_volume 12
creator Salehi, Mahsa
Lavasani, Zohre Miri
Keshavarz Alikhani, Hani
Shokouhian, Bahare
Hassan, Moustapha
Najimi, Mustapha
Vosough, Massoud
description Liver cancer is a significant contributor to the cancer burden, and its incidence rates have recently increased in almost all countries. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is the second leading cause of cancer-related deaths worldwide. Because of the late diagnosis and lack of efficient therapeutic modality for advanced stages of HCC, the death rate continues to increase by ~2–3% per year. Circulating tumor cells (CTCs) are promising tools for early diagnosis, precise prognosis, and follow-up of therapeutic responses. They can be considered to be an innovative biomarker for the early detection of tumors and targeted molecular therapy. In this review, we briefly discuss the novel materials and technologies applied for the practical isolation and detection of CTCs in HCC. Also, the clinical value of CTC detection in HCC is highlighted.
doi_str_mv 10.3390/cells12182260
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_fe41cc4d1b29457697abc28a64d17093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A766928190</galeid><doaj_id>oai_doaj_org_article_fe41cc4d1b29457697abc28a64d17093</doaj_id><sourcerecordid>A766928190</sourcerecordid><originalsourceid>FETCH-LOGICAL-c564t-59d072beb3eddf8ea94a897581b64fa45f1c41178528384af2d33511789b4b9c3</originalsourceid><addsrcrecordid>eNptkk1r3DAQhk1ooSHNsXdDL7040Zct6VTCNk0CgfaQnnoQY1naaLGlrWQX8u87zoaSLZUEEu-880gzqKo-UHLBuSaX1o1joYwqxjpyUp0yInkjBNFvXp3fVeel7AgORTtK2tPq5yZku4wwh7itH5Yp5XqzkmrAVX_PaQrlOZTSWHuMXkMen-ovbnZ2DinWyde3bg9zWh-AIMyHbENME7yv3noYizt_2c-qH1-vHza3zf23m7vN1X1j207MTasHIlnveu6GwSsHWoDSslW074QH0XpqBaVStUxxJcCzgfN2FXQvem35WXV34A4JdmafwwT5ySQI5llIeWsgz8GOzngnqLVioD3TopWdltBbpqBDSRLNkfX5wNov_eQG6-KcYTyCHkdieDTb9NtgN5lUnUbCpxdCTr8WV2aDLVybA9GlpRimJKGCM0rQ-vEf6y4tOWKv0IUoZJJXri1gBSH6hBfbFWquZNdppqheXRf_ceEc3BRsis4H1I8SmkOCzamU7PzfIikx65cyR1-K_wEqxb0i</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2869310500</pqid></control><display><type>article</type><title>Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Salehi, Mahsa ; Lavasani, Zohre Miri ; Keshavarz Alikhani, Hani ; Shokouhian, Bahare ; Hassan, Moustapha ; Najimi, Mustapha ; Vosough, Massoud</creator><creatorcontrib>Salehi, Mahsa ; Lavasani, Zohre Miri ; Keshavarz Alikhani, Hani ; Shokouhian, Bahare ; Hassan, Moustapha ; Najimi, Mustapha ; Vosough, Massoud</creatorcontrib><description>Liver cancer is a significant contributor to the cancer burden, and its incidence rates have recently increased in almost all countries. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is the second leading cause of cancer-related deaths worldwide. Because of the late diagnosis and lack of efficient therapeutic modality for advanced stages of HCC, the death rate continues to increase by ~2–3% per year. Circulating tumor cells (CTCs) are promising tools for early diagnosis, precise prognosis, and follow-up of therapeutic responses. They can be considered to be an innovative biomarker for the early detection of tumors and targeted molecular therapy. In this review, we briefly discuss the novel materials and technologies applied for the practical isolation and detection of CTCs in HCC. Also, the clinical value of CTC detection in HCC is highlighted.</description><identifier>ISSN: 2073-4409</identifier><identifier>EISSN: 2073-4409</identifier><identifier>DOI: 10.3390/cells12182260</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Antibodies ; Antigens ; Biomarkers ; Biopsy ; Cancer cells ; Cancer therapies ; circulating tumor cells ; Diagnosis ; early diagnosis ; Epidermal growth factor ; Flow cytometry ; HCC biomarker ; Hepatocellular carcinoma ; Hepatoma ; Identification and classification ; Liver cancer ; Metastasis ; Physiological aspects ; Review ; Tumor cells ; Tumors</subject><ispartof>Cells (Basel, Switzerland), 2023-09, Vol.12 (18), p.2260</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c564t-59d072beb3eddf8ea94a897581b64fa45f1c41178528384af2d33511789b4b9c3</citedby><cites>FETCH-LOGICAL-c564t-59d072beb3eddf8ea94a897581b64fa45f1c41178528384af2d33511789b4b9c3</cites><orcidid>0000-0002-1666-2258 ; 0000-0002-7329-9635 ; 0000-0003-1927-5859 ; 0000-0001-7005-5072 ; 0000-0001-5924-4366</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2869310500/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2869310500?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,25734,27905,27906,36993,36994,44571,53772,53774,74875</link.rule.ids></links><search><creatorcontrib>Salehi, Mahsa</creatorcontrib><creatorcontrib>Lavasani, Zohre Miri</creatorcontrib><creatorcontrib>Keshavarz Alikhani, Hani</creatorcontrib><creatorcontrib>Shokouhian, Bahare</creatorcontrib><creatorcontrib>Hassan, Moustapha</creatorcontrib><creatorcontrib>Najimi, Mustapha</creatorcontrib><creatorcontrib>Vosough, Massoud</creatorcontrib><title>Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma</title><title>Cells (Basel, Switzerland)</title><description>Liver cancer is a significant contributor to the cancer burden, and its incidence rates have recently increased in almost all countries. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is the second leading cause of cancer-related deaths worldwide. Because of the late diagnosis and lack of efficient therapeutic modality for advanced stages of HCC, the death rate continues to increase by ~2–3% per year. Circulating tumor cells (CTCs) are promising tools for early diagnosis, precise prognosis, and follow-up of therapeutic responses. They can be considered to be an innovative biomarker for the early detection of tumors and targeted molecular therapy. In this review, we briefly discuss the novel materials and technologies applied for the practical isolation and detection of CTCs in HCC. Also, the clinical value of CTC detection in HCC is highlighted.</description><subject>Antibodies</subject><subject>Antigens</subject><subject>Biomarkers</subject><subject>Biopsy</subject><subject>Cancer cells</subject><subject>Cancer therapies</subject><subject>circulating tumor cells</subject><subject>Diagnosis</subject><subject>early diagnosis</subject><subject>Epidermal growth factor</subject><subject>Flow cytometry</subject><subject>HCC biomarker</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatoma</subject><subject>Identification and classification</subject><subject>Liver cancer</subject><subject>Metastasis</subject><subject>Physiological aspects</subject><subject>Review</subject><subject>Tumor cells</subject><subject>Tumors</subject><issn>2073-4409</issn><issn>2073-4409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1r3DAQhk1ooSHNsXdDL7040Zct6VTCNk0CgfaQnnoQY1naaLGlrWQX8u87zoaSLZUEEu-880gzqKo-UHLBuSaX1o1joYwqxjpyUp0yInkjBNFvXp3fVeel7AgORTtK2tPq5yZku4wwh7itH5Yp5XqzkmrAVX_PaQrlOZTSWHuMXkMen-ovbnZ2DinWyde3bg9zWh-AIMyHbENME7yv3noYizt_2c-qH1-vHza3zf23m7vN1X1j207MTasHIlnveu6GwSsHWoDSslW074QH0XpqBaVStUxxJcCzgfN2FXQvem35WXV34A4JdmafwwT5ySQI5llIeWsgz8GOzngnqLVioD3TopWdltBbpqBDSRLNkfX5wNov_eQG6-KcYTyCHkdieDTb9NtgN5lUnUbCpxdCTr8WV2aDLVybA9GlpRimJKGCM0rQ-vEf6y4tOWKv0IUoZJJXri1gBSH6hBfbFWquZNdppqheXRf_ceEc3BRsis4H1I8SmkOCzamU7PzfIikx65cyR1-K_wEqxb0i</recordid><startdate>20230901</startdate><enddate>20230901</enddate><creator>Salehi, Mahsa</creator><creator>Lavasani, Zohre Miri</creator><creator>Keshavarz Alikhani, Hani</creator><creator>Shokouhian, Bahare</creator><creator>Hassan, Moustapha</creator><creator>Najimi, Mustapha</creator><creator>Vosough, Massoud</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-1666-2258</orcidid><orcidid>https://orcid.org/0000-0002-7329-9635</orcidid><orcidid>https://orcid.org/0000-0003-1927-5859</orcidid><orcidid>https://orcid.org/0000-0001-7005-5072</orcidid><orcidid>https://orcid.org/0000-0001-5924-4366</orcidid></search><sort><creationdate>20230901</creationdate><title>Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma</title><author>Salehi, Mahsa ; Lavasani, Zohre Miri ; Keshavarz Alikhani, Hani ; Shokouhian, Bahare ; Hassan, Moustapha ; Najimi, Mustapha ; Vosough, Massoud</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c564t-59d072beb3eddf8ea94a897581b64fa45f1c41178528384af2d33511789b4b9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibodies</topic><topic>Antigens</topic><topic>Biomarkers</topic><topic>Biopsy</topic><topic>Cancer cells</topic><topic>Cancer therapies</topic><topic>circulating tumor cells</topic><topic>Diagnosis</topic><topic>early diagnosis</topic><topic>Epidermal growth factor</topic><topic>Flow cytometry</topic><topic>HCC biomarker</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatoma</topic><topic>Identification and classification</topic><topic>Liver cancer</topic><topic>Metastasis</topic><topic>Physiological aspects</topic><topic>Review</topic><topic>Tumor cells</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salehi, Mahsa</creatorcontrib><creatorcontrib>Lavasani, Zohre Miri</creatorcontrib><creatorcontrib>Keshavarz Alikhani, Hani</creatorcontrib><creatorcontrib>Shokouhian, Bahare</creatorcontrib><creatorcontrib>Hassan, Moustapha</creatorcontrib><creatorcontrib>Najimi, Mustapha</creatorcontrib><creatorcontrib>Vosough, Massoud</creatorcontrib><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Cells (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salehi, Mahsa</au><au>Lavasani, Zohre Miri</au><au>Keshavarz Alikhani, Hani</au><au>Shokouhian, Bahare</au><au>Hassan, Moustapha</au><au>Najimi, Mustapha</au><au>Vosough, Massoud</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma</atitle><jtitle>Cells (Basel, Switzerland)</jtitle><date>2023-09-01</date><risdate>2023</risdate><volume>12</volume><issue>18</issue><spage>2260</spage><pages>2260-</pages><issn>2073-4409</issn><eissn>2073-4409</eissn><abstract>Liver cancer is a significant contributor to the cancer burden, and its incidence rates have recently increased in almost all countries. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is the second leading cause of cancer-related deaths worldwide. Because of the late diagnosis and lack of efficient therapeutic modality for advanced stages of HCC, the death rate continues to increase by ~2–3% per year. Circulating tumor cells (CTCs) are promising tools for early diagnosis, precise prognosis, and follow-up of therapeutic responses. They can be considered to be an innovative biomarker for the early detection of tumors and targeted molecular therapy. In this review, we briefly discuss the novel materials and technologies applied for the practical isolation and detection of CTCs in HCC. Also, the clinical value of CTC detection in HCC is highlighted.</abstract><cop>Basel</cop><pub>MDPI AG</pub><doi>10.3390/cells12182260</doi><orcidid>https://orcid.org/0000-0002-1666-2258</orcidid><orcidid>https://orcid.org/0000-0002-7329-9635</orcidid><orcidid>https://orcid.org/0000-0003-1927-5859</orcidid><orcidid>https://orcid.org/0000-0001-7005-5072</orcidid><orcidid>https://orcid.org/0000-0001-5924-4366</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2073-4409
ispartof Cells (Basel, Switzerland), 2023-09, Vol.12 (18), p.2260
issn 2073-4409
2073-4409
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_fe41cc4d1b29457697abc28a64d17093
source Publicly Available Content (ProQuest); PubMed Central
subjects Antibodies
Antigens
Biomarkers
Biopsy
Cancer cells
Cancer therapies
circulating tumor cells
Diagnosis
early diagnosis
Epidermal growth factor
Flow cytometry
HCC biomarker
Hepatocellular carcinoma
Hepatoma
Identification and classification
Liver cancer
Metastasis
Physiological aspects
Review
Tumor cells
Tumors
title Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A55%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20Tumor%20Cells%20as%20a%20Promising%20Tool%20for%20Early%20Detection%20of%20Hepatocellular%20Carcinoma&rft.jtitle=Cells%20(Basel,%20Switzerland)&rft.au=Salehi,%20Mahsa&rft.date=2023-09-01&rft.volume=12&rft.issue=18&rft.spage=2260&rft.pages=2260-&rft.issn=2073-4409&rft.eissn=2073-4409&rft_id=info:doi/10.3390/cells12182260&rft_dat=%3Cgale_doaj_%3EA766928190%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c564t-59d072beb3eddf8ea94a897581b64fa45f1c41178528384af2d33511789b4b9c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2869310500&rft_id=info:pmid/&rft_galeid=A766928190&rfr_iscdi=true